Literature DB >> 12007403

PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2.

Anil Kumar Bhunia1, Klaus Piontek, Alessandra Boletta, Lijuan Liu, Feng Qian, Pei Ning Xu, F Joseph Germino, Gregory G Germino.   

Abstract

Autosomal dominant polycystic kidney disease is characterized by cyst formation in the kidney and other organs and results from mutations of PKD1 or PKD2. Previous studies suggest that their gene products have an important role in growth regulation. We now show that expression of polycystin-1 activates the JAK-STAT pathway, thereby upregulating p21(waf1) and inducing cell cycle arrest in G0/G1. This process requires polycystin-2, a channel protein, as an essential cofactor. Mutations that disrupt polycystin-1/2 binding prevent activation of the pathway. Mouse embryos lacking Pkd1 have defective STAT1 phosphorylation and p21(waf1) induction. These results suggest that one function of the polycystin-1/2 complex is to regulate the JAK/STAT pathway and explain how mutations of either gene can result in dysregulated growth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007403     DOI: 10.1016/s0092-8674(02)00716-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  168 in total

1.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Polycystin-1 regulates STAT activity by a dual mechanism.

Authors:  Jeffrey J Talbot; Jonathan M Shillingford; Shivakumar Vasanth; Nicholas Doerr; Sambuddho Mukherjee; Mike T Kinter; Terry Watnick; Thomas Weimbs
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  New insights into ciliary function: kidney cysts and photoreceptors.

Authors:  James P Calvet
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

4.  Effect of PKD1 gene missense mutations on polycystin-1 membrane topogenesis.

Authors:  Nancy M Nims; Dianne Vassmer; Robin L Maser
Journal:  Biochemistry       Date:  2010-12-29       Impact factor: 3.162

Review 5.  The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease.

Authors:  Tamina Seeger-Nukpezah; Daniel M Geynisman; Anna S Nikonova; Thomas Benzing; Erica A Golemis
Journal:  Nat Rev Nephrol       Date:  2015-04-14       Impact factor: 28.314

6.  Phosphoinositide 3-Kinase-C2α Regulates Polycystin-2 Ciliary Entry and Protects against Kidney Cyst Formation.

Authors:  Irene Franco; Jean Piero Margaria; Maria Chiara De Santis; Andrea Ranghino; Daniel Monteyne; Marco Chiaravalli; Monika Pema; Carlo Cosimo Campa; Edoardo Ratto; Federico Gulluni; David Perez-Morga; Stefan Somlo; Giorgio R Merlo; Alessandra Boletta; Emilio Hirsch
Journal:  J Am Soc Nephrol       Date:  2015-08-13       Impact factor: 10.121

Review 7.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

8.  Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis.

Authors:  Georgia Dalagiorgou; Christina Piperi; Christos Adamopoulos; Urania Georgopoulou; Antonios N Gargalionis; Anastasia Spyropoulou; Ilianna Zoi; Marjan Nokhbehsaim; Anna Damanaki; James Deschner; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

9.  Loss of polycystin-1 causes centrosome amplification and genomic instability.

Authors:  Lorenzo Battini; Salvador Macip; Elena Fedorova; Steven Dikman; Stefan Somlo; Cristina Montagna; G Luca Gusella
Journal:  Hum Mol Genet       Date:  2008-06-19       Impact factor: 6.150

10.  Src inhibition ameliorates polycystic kidney disease.

Authors:  William E Sweeney; Rodo O von Vigier; Philip Frost; Ellis D Avner
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.